Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a biotechnology company that has carved a niche in the burgeoning field of synthetic biology. Based in Boston, Massachusetts,..
Cel-Sci Corporation (NYSE: CVM) is capturing the attention of investors with its promising biotechnology portfolio and significant potential upside. Despite a modest market capitalization of $48.92..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biopharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of investors with a promising upside potential of nearly 50%...
In the dynamic world of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) is carving out a significant niche. With a focused approach on developing monoclonal antibody therapeutics..
MeiraGTx Holdings plc (MGTX) presents a captivating opportunity for investors who are willing to navigate the complex landscape of biotechnology investments. With a focus on genetic..
Personalis, Inc. (NASDAQ: PSNL) is a healthcare company with a strong foothold in the diagnostics and research industry. Headquartered in Fremont, California, Personalis is renowned for..
Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company based in Needham, Massachusetts, is garnering significant attention from investors and analysts alike, with a strong buy consensus..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) stands out in the biotechnology industry with a compelling investment narrative, driven by its innovative approach to treating retinal diseases. Based..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a company at the forefront of developing treatments for rare diseases, presents an intriguing investment opportunity with its impressive growth trajectory..
Autolus Therapeutics plc (NASDAQ: AUTL) is garnering significant attention on the investment front, especially with its remarkable potential upside of 683.20%. As a clinical-stage biopharmaceutical company,..
Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent name in the cannabis industry, engaging in the research, cultivation, processing, and distribution of medical cannabis products across..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm, is capturing the attention of investors with its significant potential upside. With a current market capitalization of..
Surmodics, Inc. (NASDAQ: SRDX), a prominent player in the healthcare sector, specializes in medical devices and in vitro diagnostics (IVD), offering a range of performance coating..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its innovative approach to drug discovery. As a clinical-stage precision medicines company, Relay..
Abivax SA (ABVX) has made remarkable strides in the biotechnology sector, capturing the attention of investors with its impressive market cap of $9.82 billion. The Paris-based..
For investors looking for high-risk, high-reward opportunities in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) has emerged as a compelling candidate. The biopharmaceutical company, headquartered..
PureTech Health plc (PRTC) may not be a household name in the biotech sector, but its remarkable 542.7% revenue growth is a figure that demands investor..
Organogenesis Holdings Inc. (NASDAQ: ORGO) stands as a compelling player in the healthcare sector, specifically within the niche of regenerative medicine. With a market capitalization of..
For investors with an appetite for high-risk, high-reward opportunities, Humacyte, Inc. (NASDAQ: HUMA) presents a compelling case. With a market cap of approximately $209.74 million, this..
Sionna Therapeutics, Inc. (NASDAQ: SION), a biopharmaceutical innovator in the healthcare sector, is capturing attention with its focused mission to develop groundbreaking treatments for cystic fibrosis..
